Maiko Iida
Funabashi, 2748510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Fusion of breast cancer MCF-7 cells with mesenchymal stem cells rearranges interallelic gene expression and enhances cancer malignancy.
Journal: Biochemical and biophysical research communications
Published: October 22, 2024
Discovery of 2-(6-{[(1R,2R)-2-hydroxycyclohexyl]amino}-4,5-dimethylpyridazin-3-yl)-5-(trifluoromethyl)phenol (ASP0965): A potent, orally active and brain-penetrable NLRP3 inflammasome inhibitor with a novel scaffold for the treatment of α-synucleinopathy.
Journal: Bioorganic & medicinal chemistry
Published: October 21, 2024
Structure-activity relationship studies of ME1111, a novel antifungal agent for topical treatment of onychomycosis.
Journal: The Journal of antibiotics
Published: September 11, 2024
Liquid chromatography-mass spectrometry analyses of polyprenyl phosphates in Escherichia coli cells in which genes for isoprenoid synthesis are amplified.
Journal: Journal of bioscience and bioengineering
Published: November 01, 2022
Suppression of phenotype of Escherichia coli mutant defective in farnesyl diphosphate synthase by overexpression of gene for octaprenyl diphosphate synthase.
Journal: Bioscience, biotechnology, and biochemistry
Published: December 02, 2017
Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenase.
Journal: Bioorganic & medicinal chemistry
Published: November 29, 2016
The Open Form Inducer Approach for Structure-Based Drug Design.
Journal: PloS one
Published: October 03, 2016
Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
Journal: Antimicrobial agents and chemotherapy
Published: July 27, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026